Associated Papers
Deep CRISPR mutagenesis characterizes the functional diversity of TP53 mutations.
Funk JS et al.
Nature Genetics, 2025
39774325 (PubMed )
Supplement: 41588_2024_2039_MOESM12_ESM.xlsx › Fig7b_d
Variable characteristics overlooked in human K-562 leukemia cell lines with a common signature.
Kasai F et al.
Scientific Reports, 2024
38671192 (PubMed )
Supplement: 41598_2024_60271_MOESM1_ESM.pdf
Synthetic lethality between TP53 and ENDOD1.
Tang Z et al.
Nature Communications, 2022
35606358 (PubMed )
Supplement: 41467_2022_30311_MOESM1_ESM.pdf
Polymorphism of VDR Gene and the Sensitivity of Human Leukemia and Lymphoma Cells to Active Forms of Vitamin D.
Gleba JJ et al.
Cancers, 2022
Synergistic effects of PRIMA-1Met (APR-246) and 5-azacitidine in TP53-mutated myelodysplastic syndromes and acute myeloid leukemia.
Maslah N et al.
Haematologica, 2020
Dysfunction of the WT1-MEG3 signaling promotes AML leukemogenesis via p53-dependent and -independent pathways.
Lyu Y et al.
Leukemia, 2017
28400619 (PubMed )
Supplement: leu2017116x1.docx
A variant by any name: quantifying annotation discordance across tools and clinical databases.
Yen JL et al.
Genome Medicine, 2017
28122645 (PubMed )
Supplement: 13073_2016_396_MOESM1_ESM.xlsx › Table_S1
Landscape of somatic mutations in 560 breast cancer whole-genome sequences.
Nik-Zainal S et al.
Nature, 2016
27135926 (PubMed )
Supplement: NIHMS68344-supplement-Supplementary_Tables_1-21.zip › nature17676-s3 › Supplementary_Table_14.Driver.Events.By.Mutation.Type.01052015.v2.xlsx › Subs.indels
Dissecting Genomic Aberrations in Myeloproliferative Neoplasms by Multiplex-PCR and Next Generation Sequencing.
Kirschner MM et al.
Plos One, 2015
Illuminator, a desktop program for mutation detection using short-read clonal sequencing.
Carr IM et al.
Genomics, 2011
Analysis of p53 mutation status in human cancer cell lines: a paradigm for cell line cross-contamination.
Berglind H et al.
Cancer Biology & Therapy, 2008
Mutation analysis of 24 known cancer genes in the NCI-60 cell line set.
Ikediobi ON et al.
Molecular Cancer Therapeutics, 2006
Select a paper to view details